VISUAL FUNCTION RESPONSE TO OCRIPLASMIN FOR THE TREATMENT OF VITREOMACULAR TRACTION AND MACULAR HOLE

被引:0
|
作者
Jackson, T. [1 ]
Verstraeten, T. [2 ]
Duchateau, L. [3 ]
Lescrauwaet, B. [4 ]
机构
[1] Kings Coll Hosp London, London, England
[2] P95, Leuven, Belgium
[3] Univ Ghent, Ghent, Belgium
[4] Xintera Ltd, London, England
关键词
D O I
10.1016/j.jval.2014.03.1681
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSS34
引用
收藏
页码:A289 / A289
页数:1
相关论文
共 50 条
  • [31] OPTICAL COHERENCE TOMOGRAPHY FEATURES ASSOCIATED WITH VITREOMACULAR TRACTION RELEASE AND MACULAR HOLE SIZE PROGRESSION FOLLOWING TREATMENT WITH OCRIPLASMIN
    Johannigmann-Malek, Navid
    Iannetta, Danilo
    Zheng, Yalin
    Kaye, Stephen B.
    Groselli, Sofia
    Kirchmair, Katharina
    Dervenis, Nikolaos
    Issa, Peter Charbel
    Baumann, Carmen
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (11): : 1923 - 1930
  • [33] Cost effectiveness of Intravitreal Ocriplasmin for vitreomacular adhesion and macular hole
    Kapoor, Kapil G.
    Waseem, Tayab
    Reinhart, Colin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [34] Jetrea (ocriplasmin) as a treatment option for symptomatic vitreomacular traction with or without macular hole (<400 μm) - first clinical experience
    Maier, Mathias M.
    Bonse, Sophia
    Frank, Christiane
    Feucht, Nikolaus
    Lohmann, Chris
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [35] Double macular hole in vitreomacular traction syndrome
    Li, Kenneth K. W.
    Lai, Jimmy S. M.
    Wong, David
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (05): : 648 - 650
  • [36] The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole
    Duker, Jay S.
    Kaiser, Peter K.
    Binder, Susanne
    de Smet, Marc D.
    Gaudric, Alain
    Reichel, Elias
    Sadda, SriniVas R.
    Sebag, Jerry
    Spaide, Richard F.
    Stalmans, Peter
    OPHTHALMOLOGY, 2013, 120 (12) : 2611 - 2619
  • [37] OUTER RETINA REFLECTIVITY CHANGES ON SD-OCT AFTER INTRAVITREAL OCRIPLASMIN FOR VITREOMACULAR TRACTION AND MACULAR HOLE
    Quezada-Ruiz, Carlos
    Pieramici, Dante J.
    Nasir, Ma'an
    Rabena, Melvin
    Steinle, Nathan
    Castellarin, Alessandro A.
    Dhoot, Dilsher
    Couvillion, Stephen
    See, Robert F.
    Avery, Robert L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1144 - 1150
  • [38] Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study
    Greven, Margaret A.
    Garg, Sunir
    Chiu, Bing
    Shah, Sumit P.
    Wolfe, Jeremy
    Fine, Howard F.
    Roth, Daniel B.
    Robinson, Joshua
    Mong, Jacob
    Hsu, Jason
    Regillo, Carl
    Ho, Allen
    Haller, Julia A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (09) : 1211 - 1215
  • [39] Treatment of vitreomacular traction with ocriplasmin in a non-reimbursed setting
    Willekens, K.
    Pinto, L. A.
    Vandewalle, E.
    Stalmans, I.
    Stalmans, P.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [40] Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice
    Ricarda G. Schumann
    Julian Langer
    Denise Compera
    Katharina Luedtke
    Markus M. Schaumberger
    Thomas Kreutzer
    Wolfgang J. Mayer
    Armin Wolf
    Siegfried G. Priglinger
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 2081 - 2089